Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-20
DOI
10.1038/srep12315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular targeted therapy for hepatocellular carcinoma: Current and future
- (2014) Jung Woo Shin WORLD JOURNAL OF GASTROENTEROLOGY
- Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model
- (2013) Yun-Hee Kim et al. CANCER LETTERS
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- miRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting
- (2012) Sooyoung Cho et al. NUCLEIC ACIDS RESEARCH
- Targeted Therapies for Hepatocellular Carcinoma
- (2011) Augusto Villanueva et al. GASTROENTEROLOGY
- Selective and efficient retardation of cancers expressing cytoskeleton-associated protein 2 by targeted RNA replacement
- (2011) Guyee Ban et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA sponges: Progress and possibilities
- (2010) M. S. Ebert et al. RNA
- Current approach in the treatment of hepatocellular carcinoma
- (2010) Luigi Rossi World Journal of Gastrointestinal Oncology
- Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer
- (2009) Y.-W. Huang et al. CANCER RESEARCH
- MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2009) F. Fornari et al. CANCER RESEARCH
- Cancer Cell Targeting with Mouse TERT-Specific Group I Intron of Tetrahymena thermophila
- (2009) Guyee Ban JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
- (2009) Brian D. Brown et al. NATURE REVIEWS GENETICS
- Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
- (2009) C Coulouarn et al. ONCOGENE
- Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo
- (2008) M-S Song et al. CANCER GENE THERAPY
- Antitumor Effects of Systemically Delivered Adenovirus Harboring Trans-Splicing Ribozyme in Intrahepatic Colon Cancer Mouse Model
- (2008) J.-S. Jeong et al. CLINICAL CANCER RESEARCH
- Micro-RNAs in Gastrointestinal and Liver Disease
- (2008) Rosa Visone et al. GASTROENTEROLOGY
- MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors
- (2008) Chiara Braconi et al. HEPATOLOGY
- MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma
- (2008) Wei-Chih Tsai et al. HEPATOLOGY
- Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice
- (2008) Noriho Iida et al. JOURNAL OF LEUKOCYTE BIOLOGY
- miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy
- (2008) Takayuki Suzuki et al. MOLECULAR THERAPY
- In Vivo Reprogramming of hTERT by Trans-splicing Ribozyme to Target Tumor Cells
- (2007) Seung-Hee Hong et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started